Iaffaioli Rosario Vincenzo - Assoc Multidisciplinary Studies Oncol & Mediterra, Piazza Nicola Amore, Naples, Italy

基本信息

浏览量：57

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Reasons Why COVID-19 Survivors Should Follow Dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations: from Hyper-Inflammation to Cardiac Dysfunctions

V Quagliariello,G. D'aiuto,R. Iaffaioli,M. Berretta,S. Buccolo,M. Iovine,A. Paccone,F. Cerrone,S. Bonanno,G. Nunnari,N. Lagana,G. Botti,N. Maurea

DOAJ (DOAJ Directory of Open Access Journals)（2021）

引用3浏览0WOS引用

Dapagliflozin Exerts Cardioprotective And Anti-Infiammatory Effects During Exposure With Doxorubicin And Trastuzumab

V. Quagliariello,A. Bonelli,A. Caronna,C. Lombari,G. Conforti,R. Iaffaioli,G. Botti,N. Maurea

EUROPEAN HEART JOURNAL SUPPLEMENTSno. G (2020): G33-G33

引用0浏览0引用

The Sglt-2 Inhibitor Empagliflozin Exerts Cardioprotective And Anti-Inflammatory Effects During Incubation With Doxorubicin Through The Leukotrienes And P65/Nf-Kb Pathway

V. Quagliariello,M. De Laurentiis,A. Bonelli,A. Caronna,C. Lombari,G. Conforti,R. Iaffaioli,G. Botti,N. Maurea

EUROPEAN HEART JOURNAL SUPPLEMENTSno. G (2020): G80-G80

引用0浏览0引用

SARS-CoV-2 Infection: NLRP3 Inflammasome As Plausible Target to Prevent Cardiopulmonary Complications

V Ouagliariello,A. Bonelli,A. Caronna, M. C. Lombari,G. Conforti,M. Libutti,R. Iaffaioli,M. Berretta,G. Botti,N. Maurea

DOAJ (DOAJ Directory of Open Access Journals)（2020）

引用17浏览0WOS引用

A New Docetaxel (Doc)-Based Triplet Regimen Does Not Improve the Outcome of Metastatic (M) or Locally Advanced (LA) Gastric Cancer (GC) As Compared with an Epirubicin (EPI) Standard Triplet Regimen: A GISCAD Trial

R. Labianca,G. Rosati,N. Fazio,L. Cavanna,D. Ferrari,M. Di Bartolomeo,S. Mosconi,M. Giordano,N. Silvestris,F. Artioli,R. V. Iaffaioli, E. A. Veltri,D. Amoroso,A. Ciarlo,S. Barni,S. Cascinu,C. Davite, A. Di Sanzo, A. Casolaro

Annals of oncology（2019）

引用0浏览0引用

Efficacy of Cetuximab Immediately after Bevacizumab: A Phase III Multicenter Trial Comparing Two Different Sequences of Cetuximab and FOLFOX in K-Ras WT Metastatic Colorectal Cancer Patients Refractory FOLFIRI/bevacizumab

Stefano Cascinu,Alberto Zaniboni,Sara Lonardi,Gerardo Rosati,Guglielmo Nasti,Monica Giordano,Domenico C. Corsi,Francesco Ferrau,Rosario Vincenz Iaffaioli,Paolo Marchetti,Massimo Aglietta,Domenico Bilancia,Monica Ronzoni,Irene Claudia Floriani,Roberto Labianca

Journal of Clinical Oncology（2016）

引用2浏览0引用

NON CONVENTIONAL FRACTIONATIONS IN RADIOTHERAPY: A NEW ALGORITHM BASED ON RADIOBIOLOGICAL COST FUNCTIONS

P. Pedicini,P. Muto,R. Vincenzo,S. Clemente, M. Michele,F. Vincenzo, C. Giovanni, R. Luciana

RADIOTHERAPY AND ONCOLOGY（2008）

引用0浏览0引用

A Dose Finding Followed by a Phase II Study of Oral UFT (uracil/tegafur) and Lv (leucovorin) Plus I.v. Mitomycin (MMC) in Patients (pts) with Metastatic Colorectal Cancer (MCRC): Phase I Results

E Maiello,M Lopez,RV Iaffaioli,R Tambaro,G Paoletti,F Giuliani,G Colucci

Journal of clinical oncology（2004）

引用0浏览0引用

Carboplatin Plus Vinorelbine, a New Well-Tolerated and Active Regimen for the Treatment of Extensive-Stage Small-Cell Lung Cancer: a Phase II Study. Gruppo Oncologico Centro-Sud-Isole

C Gridelli,F Perrone,GP Ianniello,L Brancaccio,R Vincenzo, IC Curcio,M D 'Aprile,R Cioffi,S Cigolari,A Rossi,G Palazzolo,E Veltri,M Pergola,S De Placido,C Gallo,S Monfardini,AR Bianco

Journal of clinical oncology（1998）

引用26浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn